Perrigo (PRGO) Tops Q1 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Perrigo (PRGO) Rx Price Erosion Appears To Creep Above Guided Range - Goldman Sachs
May 31, 2017 5:12 AM EDTGoldman Sachs maintains Sell on Perrigo Co. (NYSE: PRGO) price target of $68.00.
Analyst Jami Rubin writes to clients in a late Tuesday note that RX prices have eroded 11-13 percent compared with company guidance of 9-11 percent for FY 2017.
"...we calculate... More
Perrigo (PRGO) Files Form 10-Q; Reports Q1 Results
May 30, 2017 5:17 PM EDTDelivered first quarter 2017 GAAP ("reported") net sales of $1.2 billion, led by consumer-facing businesses net sales of $958 millionRealized first quarter reported net income of $72 million and reported earnings per share ("EPS") of $0.50Achieved adjusted net income of $150 million and adjusted diluted EPS of $1.05First quarter cash flow from operations was $195 million; cash flow from operations of 272% as a percentage to net income and 130% as a percentage to adjusted net income CHCI profit improvement plan yielding positive results... More
